These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Severe cyclosporine arteriolopathy with focal segmental glomerulosclerosis is not a fatal finding in chronic renal allograft failure after year 5 of transplantation using cyclosporine. Takeda A; Morozumi K; Koyama K; Yoshida A; Uchida K; Tominaga Y; Haba T; Oikawa T; Usami T; Sugito K; Takeuchi O; Fujinami T; Yokoyama I; Takagi H Transplant Proc; 1997; 29(1-2):96-9. PubMed ID: 9123169 [No Abstract] [Full Text] [Related]
7. [A case of subclinical IgA nephropathy and cyclosporin associated arteriolopathy diagnosed by non-episode biopsy of graft kidney after renal transplantation]. Namba Y; Kyakuno M; Nakamura T; Yamashiro H; Okada M; Toki K; Ichimaru N; Kokado Y; Takahara S; Okuyama A; Oka K; Imai E; Kyo M Hinyokika Kiyo; 1999 May; 45(5):349-53. PubMed ID: 10410319 [TBL] [Abstract][Full Text] [Related]
8. Clinical and histological analysis of chronic tacrolimus nephrotoxicity in renal allografts. Shimizu T; Ishida H; Shirakawa H; Omoto K; Tanabe K; Yamaguchi Y Transplant Proc; 2008 Sep; 40(7):2370-2. PubMed ID: 18790237 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology? Morozumi K; Takeda A; Uchida K; Mihatsch MJ Transplant Proc; 2004 Mar; 36(2 Suppl):251S-256S. PubMed ID: 15041348 [TBL] [Abstract][Full Text] [Related]
14. Is a late graft biopsy at 3 years after transplantation effective for improving the long-term outcome of renal allografts using cyclosporine? Morozumi K; Takeda A; Uchida K; Oda A; Oikawa T; Sugito K; Kodera K; Fujinami T; Tominaga Y; Yoshida A Transplant Proc; 1994 Apr; 26(2):945-8. PubMed ID: 8171713 [No Abstract] [Full Text] [Related]
15. A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: are the morphologic characteristics of FK506 and CyA nephrotoxicity similar? Morozumi K; Sugito K; Oda A; Takeuchi O; Fukuda M; Usami T; Oikawa T; Fujinami T; Koyama K; Takeda A; Yoshida A; Haba T; Tominaga Y; Uchida K; Yokoyama I; Takagi H Transplant Proc; 1996 Apr; 28(2):1076-8. PubMed ID: 8623232 [No Abstract] [Full Text] [Related]
16. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome. Wiener Y; Nakhleh RE; Lee MW; Escobar FS; Venkat KK; Kupin WL; Mozes MF Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835 [TBL] [Abstract][Full Text] [Related]
17. Arteriolopathy in non-episode biopsies of renal transplant allograft. Toki K; Kyo M; Takahara S; Morozumi K; Ichimaru N; Tanaka T; Wang JD; Permpongkosol S; Oka K; Imai E; Miyamoto M; Kyakuno M; Nakamura T; Kojima Y; Kokado Y; Okuyama A Clin Transplant; 2000; 14 Suppl 3():21-4. PubMed ID: 11092348 [TBL] [Abstract][Full Text] [Related]
18. Ultrastructural study of cyclosporine-associated arteriolopathy in renal allografts. Yamaguchi Y; Teraoka S; Yagisawa T; Takahashi K; Toma H; Ota K Transplant Proc; 1989 Feb; 21(1 Pt 2):1517-22. PubMed ID: 2652489 [No Abstract] [Full Text] [Related]
19. Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy. Young BA; Burdmann EA; Johnson RJ; Andoh T; Bennett WM; Couser WG; Alpers CE Kidney Int; 1995 Aug; 48(2):431-8. PubMed ID: 7564110 [TBL] [Abstract][Full Text] [Related]
20. Vasculopathy in cyclosporine-treated renal allografts: possible protection by diltiazem. Choy BY; Walker RG; Becker GJ Clin Transplant; 1994 Jun; 8(3 Pt 1):271-3. PubMed ID: 8061366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]